The value of a second transurethral resection in evaluating patients with bladder tumours.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12600426.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the usefulness of a second transurethral resection for superficial and muscle-invasive bladder tumours. A review of the literature relevant to repeat resection for bladder tumours was conducted using Medline Services. Transurethral resection of the bladder has two shortcomings: underestimating clinical stage, and overlooking other lesions. A second transurethral resection, when performed 2-6 weeks after the initial resection, corrects clinical staging errors in 9-49% of cases and detects residual tumour in 26-83% of cases. A second resection is particularly warranted for T1 tumours since 2-28% of them prove to be muscle-invasive, thus requiring a change in management. For muscle-invasive tumours, a second resection may be performed only if bladder sparing is being considered, as it helps to exclude the presence of tumour sites contra-indicating conservative treatment. A second transurethral bladder resection may be warranted for T1 tumours, and for invasive tumours when a bladder preservation is planned.
Medical subject headings
- Cystectomy
- Urinary Bladder Neoplasms